Dynavax Technologies


Stock Update (NASDAQ:DVAX): Dynavax Reports Fourth Quarter and Year End 2014 Financial Results

Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the fourth quarter and year ended December 31, 2014. The Company had $122.

Company Update (NASDAQ:DVAX): Dynavax Announces Second Independent DSMB Recommendation to Continue Phase 3 Study of HEPLISAV-B(TM)

Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the independent Data and Safety Monitoring Board (DSMB) charged with periodically reviewing safety data from …

Cowen Maintains Outperform On Dynavax Following R&D Day

Cowen analyst Phil Nadeau maintained an Outperform rating on Dynavax Technologies (NASDAQ:DVAX) and raised his price target to $60 (from $6) to reflect the recent 10:1 reverse …

MLV Reiterates Buy On Dynavax Technologies As It Regains Rights To DV1179

In a research report sent to investors today, MLV analyst Vernon Bernardino reiterated a Buy rating on Dynavax Technologies (NASDAQ:DVAX), as the company announced …

William Blair Reiterates Outperform On Dynavax Following Completion Of Enrollment In HBV-23

In a research report issued today, William Blair analyst Y Katherine Xu reiterated an Outperform rating on Dynavax Technologies (NASDAQ:DVAX) with a $4 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts